Avience Biomedicals IPO GMP Today, Price & Details
Avience Biomedicals IPO GMP Today, Price Band, Subscription Status, Allotment & Listing Details
About Avience Biomedicals
Avience Biomedicals is planning to raise capital through an sme initial public offering (IPO) on the NSE. The shares are being offered at a price band of ₹196 to ₹196 with a face value of ₹10 per share. Retail investors can apply for a minimum of 1200 shares (1 lot), requiring an investment of ₹235,200. The total issue size is ₹30.24 Cr. The IPO opens on 18 Jun 2026 and closes on 22 Jun 2026. The company reported revenue of ₹41.84 Cr with PAT of ₹5.74 Cr.
Avience Biomedicals IPO Details
| Company Name | Avience Biomedicals |
|---|---|
| IPO Type | SME |
| Exchange | NSE |
| Price Band | ₹196 - ₹196 |
| Face Value | ₹10 per share |
| Lot Size | 1200 shares |
| Min Investment | ₹235,200 |
| Total Issue Size | ₹30.24 Cr |
|---|---|
| Fresh Issue | ₹30.24 Cr |
| IPO Status | Upcoming |
Avience Biomedicals IPO Dates
Avience Biomedicals IPO GMP Today
The Grey Market Premium (GMP) for Avience Biomedicals IPO is not available.
Avience Biomedicals IPO — Key Highlights
- Avience Biomedicals is a sme IPO listing on NSE with a price band of ₹196 to ₹196 per share.
- The total issue size is ₹30.24 Cr.
- Minimum lot size of 1200 shares, requiring ₹235,200 investment.
- Revenue of ₹41.84 Cr with PAT of ₹5.74 Cr.
- P/E ratio of 15.66x.
Avience Biomedicals Financial Performance
| Metric (₹ Cr) | FY 2024 | FY 2025 | 10M FY 2026 |
|---|---|---|---|
| Revenue | 23.96 | 45.24 | 41.84 |
| Expenses | 21.42 | 36.17 | 34.06 |
| Net Income (PAT) | 2.14 | 7.23 | 5.74 |
| Margin (%) | 8.93% | 15.98% | 13.72% |
Avience Biomedicals IPO Valuations & Key Metrics
Valuation Ratios
| EPS | ₹12.52 |
|---|---|
| P/E Ratio | 15.66x |
| NAV | ₹56.50 |
| Debt/Equity | 0.970 |
Return Metrics
| RONW (%) | 49.89% |
|---|---|
| ROCE (%) | 24.88% |
| EBITDA Margin | 25.22% |
| Employees | 75 |
Avience Biomedicals IPO — Frequently Asked Questions
What is Avience Biomedicals IPO GMP today?
As of today, the Grey Market Premium (GMP) for Avience Biomedicals IPO is not available at this time. GMP values are updated daily based on grey market activity.
What is the price band and lot size of Avience Biomedicals IPO?
Avience Biomedicals IPO has a price band of ₹196 to ₹196 per equity share with a face value of ₹10. The minimum lot size is 1200 shares, requiring a minimum investment of ₹235,200 at the upper band.
What are the important dates for Avience Biomedicals IPO?
Avience Biomedicals IPO opens for subscription on 18 Jun 2026 and closes on 22 Jun 2026. Allotment is expected on 23 Jun 2026. The shares are expected to list on NSE on 25 Jun 2026.
How can I apply for Avience Biomedicals IPO?
You can apply for Avience Biomedicals IPO through your bank's net banking ASBA facility or via UPI-based application through any stockbroker platform. Ensure you have sufficient funds in your bank account as the amount will be blocked until allotment.